National Health Investors, Inc. (NYSE:NHI) Given Consensus Rating of “Moderate Buy” by Brokerages

National Health Investors, Inc. (NYSE:NHI) has earned a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $86.8333.

Several research firms have weighed in on NHI. Cantor Fitzgerald set a $85.00 price target on National Health Investors in a research note on Monday, January 5th. Wells Fargo & Company boosted their price target on National Health Investors from $85.00 to $86.00 and gave the company an “equal weight” rating in a research note on Friday, March 27th. Truist Financial boosted their price target on National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a research note on Thursday, March 12th. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price on the stock. in a research note on Tuesday, January 20th. Finally, National Bank Financial set a $85.00 target price on National Health Investors in a research note on Tuesday, January 20th.

National Health Investors Stock Down 0.3%

National Health Investors stock opened at $85.73 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. The business’s 50-day simple moving average is $85.58 and its two-hundred day simple moving average is $80.35. The company has a market cap of $4.15 billion, a PE ratio of 28.39, a PEG ratio of 4.66 and a beta of 0.63. National Health Investors has a fifty-two week low of $68.80 and a fifty-two week high of $91.38.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.01). The firm had revenue of $105.82 million for the quarter, compared to analysts’ expectations of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.24 EPS. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Equities analysts anticipate that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be paid a $0.92 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.3%. National Health Investors’s dividend payout ratio is presently 121.85%.

Institutional Trading of National Health Investors

A number of hedge funds have recently modified their holdings of the stock. Renaissance Group LLC boosted its position in National Health Investors by 3.8% during the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after purchasing an additional 117 shares in the last quarter. GAMMA Investing LLC boosted its position in National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 136 shares in the last quarter. Captrust Financial Advisors boosted its position in National Health Investors by 1.7% during the fourth quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock worth $680,000 after purchasing an additional 146 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in National Health Investors by 5.0% during the third quarter. PNC Financial Services Group Inc. now owns 3,731 shares of the real estate investment trust’s stock worth $297,000 after purchasing an additional 177 shares in the last quarter. Finally, Arizona State Retirement System boosted its position in National Health Investors by 1.4% during the third quarter. Arizona State Retirement System now owns 13,818 shares of the real estate investment trust’s stock worth $1,099,000 after purchasing an additional 191 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.